Plasma Soluble Glycoprotein VI: A Biomarker of Bleeding

THROMBOSIS AND HAEMOSTASIS（2024）

引用 0|浏览9

暂无评分

摘要

David J. Schneider is the named inventor on a patent (Patent No.: 10,502,737) that proposes the use of FcγRIIa for assaying platelet reactivity and treatment selection.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要